⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2946881 | 1.00 | — | — | |
| SCHEMBL111180 | 1.00 | — | — | |
| SCHEMBL30466519 | 0.81 | — | — | |
| SCHEMBL18901885 | 0.79 | — | — | |
| SCHEMBL108664 | 0.77 | TSHR (0.53) | — | |
| SCHEMBL12387806 | 0.77 | — | — | |
| SCHEMBL12387819 | 0.77 | — | — | |
| SCHEMBL464573 | 0.77 | TSHR (0.53) | — | |
| SCHEMBL14928537 | 0.77 | — | — | |
| SCHEMBL26336 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7750048-B2 | GPR40 agonists | JANSSEN PHARMACEUTICA NV (BE) | 2010-07-06 | — | — | US | disclosed |
| US-20080176912-A1 | GPR40 AGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-24 | — | — | US | disclosed |
| US-7303695-B2 | Process for producing optically active liquid crystalline polymer compound | NIPPON OIL CORPORATION (JP) | 2007-12-04 | — | — | US | disclosed |
| US-20060157672-A1 | Process For Producing Optically Active Liquid Crystalline Polymer Compound | NIPPON OIL CORPORATION | 2006-07-20 | — | — | US | disclosed |
| US-6034754-A | Liquid crystal display device with compensating film(s) | NIPPON OIL COMPANY, LIMITED | 2000-03-07 | — | — | US | disclosed |
| EP-0881521-A2 | Liquid crystal display device | NIPPON OIL CO., LTD. (JP) | 1998-12-02 | — | — | EP | disclosed |